Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$467M |
| 2 |
L3Harris
LHX
|
+$370M |
| 3 |
Medtronic
MDT
|
+$364M |
| 4 |
PayPal
PYPL
|
+$351M |
| 5 |
NXP Semiconductors
NXPI
|
+$264M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$445M |
| 2 |
Pfizer
PFE
|
+$386M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$375M |
| 4 |
FDC
First Data Corporation
FDC
|
+$280M |
| 5 |
AGN
Allergan plc
AGN
|
+$223M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.98% |
| 2 | Financials | 13.01% |
| 3 | Healthcare | 10.66% |
| 4 | Industrials | 8.3% |
| 5 | Consumer Discretionary | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Cars.com
CARS
$676M
| $852K | ﹤0.01% |
94,899
-169,060
| -64% | -$2.28M |
|
3027
Takeda Pharmaceutical
TAK
$53.7B
| $851K | ﹤0.01% |
49,533
-5,219
| -10% | -$90.3K |
|
3028
Global X Silver Miners ETF NEW
SIL
$4.22B
| $849K | ﹤0.01% |
30,212
+3,769
| +14% | +$109K |
|
3029
Stagwell
STGW
$2.13B
| $849K | ﹤0.01% |
301,007
-124,500
| -29% | -$312K |
|
|
ARNA
3030
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $845K | ﹤0.01% |
18,461
-20,064
| -52% | -$1.13M |
|
3031
CRISPR Therapeutics
CRSP
$4.88B
| $843K | ﹤0.01% |
20,571
-37
| -0.2% | -$1.77K |
|
3032
FlexShares STOXX Global ESG Select Index Fund
ESGG
$114M
| $842K | ﹤0.01% |
8,477
+655
| +8% | +$64.6K |
|
3033
VanEck Short Muni ETF
SMB
$311M
| $842K | ﹤0.01% |
47,596
-28,819
| -38% | -$512K |
|
3034
iShares US Basic Materials ETF
IYM
$1.21B
| $840K | ﹤0.01% |
9,105
-894
| -9% | -$82.3K |
|
3035
Titan International
TWI
$466M
| $839K | ﹤0.01% |
311,023
-18,185
| -6% | -$59.8K |
|
3036
iShares MSCI Sweden ETF
EWD
$594M
| $838K | ﹤0.01% |
28,449
+1,045
| +4% | +$30.7K |
|
3037
Barnes & Noble Education
BNED
$447M
| $834K | ﹤0.01% |
2,671
+422
| +19% | +$148K |
|
3038
WPP
WPP
$4.39B
| $829K | ﹤0.01% |
13,256
+1,684
| +15% | +$101K |
|
3039
Genmab
GMAB
$17.6B
| $827K | ﹤0.01% |
+40,852
| New | +$805K |
|
|
EOT
3040
Eaton Vance National Municipal Opportunities Trust
EOT
$273M
| $825K | ﹤0.01% |
36,554
+2,736
| +8% | +$62.7K |
|
|
HEQ
3041
John Hancock Hedged Equity & Income Fund
HEQ
$139M
| $821K | ﹤0.01% |
59,308
+10,761
| +22% | +$149K |
|
3042
iShares Global Financials ETF
IXG
$686M
| $821K | ﹤0.01% |
12,818
-678
| -5% | -$42.6K |
|
3043
ProShares Hedge Replication ETF
HDG
$22.2M
| $816K | ﹤0.01% |
18,023
+5,633
| +45% | +$255K |
|
3044
Peabody Energy
BTU
$2.65B
| $812K | ﹤0.01% |
55,091
-31,503
| -36% | -$614K |
|
3045
Rhythm Pharmaceuticals
RYTM
$7.05B
| $812K | ﹤0.01% |
+37,610
| New | +$807K |
|
|
SHYF
3046
DELISTED
The Shyft Group
SHYF
| $812K | ﹤0.01% |
59,227
+8,369
| +16% | +$102K |
|
3047
Scotiabank
BNS
$108B
| $808K | ﹤0.01% |
14,212
+770
| +6% | +$41.3K |
|
|
WIL
3048
DELISTED
iPath Women in Leadership ETN
WIL
| $804K | ﹤0.01% |
11,370
+1,051
| +10% | +$74.8K |
|
|
PTLA
3049
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $804K | ﹤0.01% |
29,966
-23,226
| -44% | -$652K |
|
3050
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$471M
| $803K | ﹤0.01% |
14,677
+3,549
| +32% | +$195K |
|
Similar funds
Ameriprise's Q3 2019 Portfolio in Review
As of Q3 2019, Ameriprise held 3,857 positions worth $223B, down 0.05% from $223B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q3 2019 filing shows 145 new, 1,599 increased, 1,844 reduced and 155 closed positions. Its largest new stake was argenx: 410,155 shares worth $46.7M. The largest sale was Boeing, an estimated $445M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2019 buy was argenx: 410,155 shares worth $46.7M.
- Ameriprise added most to Fiserv Inc in Q3 2019, an estimated $467M increase.
- Ameriprise's biggest Q3 2019 reduction was Boeing, cutting an estimated $445M.
- Ameriprise fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $375M.
- Ameriprise's ten largest holdings make up 13% of its $223B portfolio in Q3 2019.
- Ameriprise opened 145 new positions and closed 155 in Q3 2019.
- Ameriprise's portfolio value fell 0.05% quarter-over-quarter to $223B.
Based on Ameriprise's 13F filing for Q3 2019, filed 14 Nov 2019.